January 26, 2021 — Innovation in obesity care has come a long way. Back in 2010, Sanofi was smarting from the spectacular failure of rimonabant and big pharma was closing down research programs in obesity. But Novo Nordisk forged ahead with an ambitious program and now has a successful portfolio in obesity care to show for it. Nonetheless, we […]
December 23, 2020 — China is going to eliminate food waste and fight obesity in a single stroke of regulation. How, you ask? Operation Empty Plate will expand into law. China will make it a crime to promote food waste, including overeating. The hilarity of naive efforts to regulate food marketing never disappoints. Stiff Fines for Bad Marketing Right […]
December 10, 2020 — News from Eli Lilly and Company suggests that we may soon see a new drug that offers two-for-one efficacy – a clinical benefit in both obesity and diabetes. The company announced yesterday that tirzepatide produced good results against endpoints for both diseases in a phase 3 RCT. In this study, called SURPASS-1, researchers tested three […]
December 7, 2020 — Friday marked an important milestone in progress toward better treatments for obesity. Novo Nordisk submitted semaglutide to FDA for approval in treating obesity. So we may see approval for this important new drug in the second half of next year. Why so important? We have two reasons. A Step Forward in Effectiveness The first reason […]
November 28, 2020 — This is the ultimate Friday news dump. FDA approved a highly innovative, highly targeted treatment for obesity – setmelanotide – Wednesday night. Just before a four-day holiday. The company announced in on Friday – timing one would typically choose for news they want to hide. But this is really good news for the treatment of […]
November 22, 2020 — This month has brought considerable progress on NASH treatments. Yet it’s hard to know when we will have real progress in medical care for this silent epidemic. Getting FDA to yes on new treatments seems to be a challenge. Nonetheless, we have news of two new studies that suggest promise for new NASH treatments. One […]
November 10, 2020 — Saxenda (liraglutide) is on the brink of becoming a billion dollar drug for obesity. Yet its effectiveness in obesity is modest. On average, a person taking it might expect that their weight would go down by about eight percent. Of course, some people will have a much bigger benefit. But others will have less or […]
November 8, 2020 — Even chaos is a business opportunity. So it seems that the market for calm is booming – both as a state of mind and a popular health app. This week the company behind the health app named Calm seized an opportunity. They sponsored those jarring election news alerts on CNN that were delivering the precise […]
October 25, 2020 — After two decades of really bad publicity, sugar is reinventing itself. Just last week, FDA finalized its rules for allulose, a rare but natural form of sugar. It looks and tastes a lot like regular sugar, though it’s about one third less sweet. But the really sweet deal is that the final rule from FDA […]
September 9, 2020 — Eight years of change packed into one month. COVID-19 has changed food shopping. All of a sudden, everything about the ways we hunt and gather our meals is different. For one thing, we’re making fewer trips and more clicks. But we’re buying more and buying in new ways. Professor Anna Nagurney tells the New York […]
